Answers are grounded in this paper and cite their sources.
Calcineurin (CN) is the primary Ca2+-calmodulin regulated phosphatase in animals and fungi and dephosphorylates dozens of substrates involved in gene expression, cytoskeletal organization, and nuclear trafficking, among many others. CN is both recruited to Ca2+ signals and recognizes substrates via binding to two short linear motifs (SLIMs). The first, PxIxIT, anchors CN to substrates and controls CN localization by interacting with scaffolding proteins. The second, LxVP, helps orient substrates for dephosphorylation at its catalytic center. Together, these two SLIMs cooperate to facilitate dephosphorylation and blocking either inhibits CN function. We have identified a new class of substrates that contain a single composite LxVPxIxIT motif. Due to the distance between the LxVP and PxIxIT binding sites on CN, one composite motif is unable to occupy both sites simultaneously. C16orf74 is a largely uncharacterized protein containing a composite motif. It has been identified as a prognostic marker for pancreatic cancer and recruits CN to membranes where they cooperate in promoting invasion and proliferation in cultured cells. We have shown that knocking down C16orf74 in breast cancer cell lines results in a significant reduction in estrogen receptor alpha protein levels, a protein stabilized by CN-mediated dephosphorylation. Using C16orf74 as a model, we have shown that not only can proteins with composite SLIMs be dephosphorylated by CN, but these novel motifs facilitate unique modes of CN regulation. In vitro and cell-based assays have revealed that CN directly dephosphorylates C16orf74 and both the LxVP and PxIxIT components of the composite motif are necessary for dephosphorylation in cells. The two motifs cooperate by forming multimers with CN. One molecule of C16orf74 recruits CN to membranes via PxIxIT binding, allowing others to engage through the LxVP motif to be dephosphorylated. As a result, dephosphorylation is controlled by the ratio of C16orf74 to CN, as multimers will only form when C16orf74 is in excess. This is supported by our in vitro phosphatase assays that show that unlike conventional substrates, C16orf74 dephosphorylation becomes less efficient when CN is in excess and multimers are unlikely to form. This mechanism provides a secondary switch by which CN activities can be regulated, as both a Ca2+ signal and a mechanism to cluster C16orf74 at membrane subdomains are necessary to trigger dephosphorylation. We have shown that C16orf74 is palmitoylated which targets both proteins to membranes and may facilitate clustering. Interestingly, dephosphorylation drastically reduces C16orf74-CN binding affinity and may act to release CN to engage other substrates at membranes, like the estrogen receptor. We are currently investigating how C16orf74, CN, and this new mode of regulation conferred by these composite motifs help to maintain high estrogen receptor levels in breast cancer cells. Finally, C16orf74 is not the only protein containing a composite motif and we believe that the regulatory principles we have uncovered here may apply to proteins with similar novel composite SLIMs. This work is supported by NIH grant NIGMS R35GM136243 and through the Stanford Cell and Molecular Training Program (NIH 5 T32 GM007276).
No takes yet. Share an insight, caveat, or question.
Bradburn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: